Literature DB >> 18079996

Macrophage migration inhibitory factor in pediatric patients undergoing surgery for congenital heart repair.

Sanah Merchant1, Sumekala Nadaraj, Devyani Chowdhury, Vincent A Parnell, Cristina Sison, Edmund J Miller, Kaie Ojamaa.   

Abstract

Macrophage migration inhibitory factor (MIF), a proinflammatory mediator, has been shown to be elevated following heart surgery in adults and may be associated with several postoperative complications, including cardiac and pulmonary dysfunction. In this study, we aimed to measure perioperative plasma MIF, interleukin (IL)-8, and free T4 in 20 children age <4 years undergoing surgical repair of congenital heart lesions with left ventricular volume overload, and to determine whether the response of these mediators determined postoperative outcomes. Plasma samples were obtained preoperatively, immediately on arrival in the pediatric intensive care unit (PICU), and at 12, 24, and 48 h. Patients were continuously monitored in the PICU, and data were recorded daily for therapeutic and monitoring procedures that reflected the invasiveness, intensity, and complexity of care rendered (therapeutic interventional scoring system, TISS). Preoperative plasma MIF, IL-8, and free T4 were not different from age-matched healthy children. However, plasma MIF and IL-8 increased significantly 2 h after completion of cardiopulmonary bypass, and then normalized within 24 h. Peak postoperative levels of MIF (48 +/- 24 ng/mL) and IL-8 (79 +/- 57 pg/mL) correlated significantly with duration of cardiopulmonary bypass. The magnitude of the postoperative increase in plasma MIF was associated with increased number of days required for mechanical ventilation (r = 0.553; P = 0.012), and peak plasma IL-8 correlated significantly with the fraction of inhaled oxygen (FiO(2)) required immediately after surgery (r = 0.510; P = 0.02). Higher circulating MIF levels correlated significantly with increased inotropic support requirements on the second postoperative day, whereas higher postoperative IL-8 levels were associated with higher TISS scores, suggesting increased need for postoperative medical care. These data suggest a potential negative effect of high circulating levels of MIF in the immediate postoperative period on respiratory and cardiovascular functions, and support the development of therapeutic strategies targeting MIF function in this clinical setting.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18079996      PMCID: PMC2136429          DOI: 10.2119/2007-00086.Merchant

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  34 in total

1.  A prospective randomized clinical study of thyroid hormone treatment after operations for complex congenital heart disease.

Authors:  D Chowdhury; K Ojamaa; V A Parnell; C McMahon; C P Sison; I Klein
Journal:  J Thorac Cardiovasc Surg       Date:  2001-11       Impact factor: 5.209

2.  Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin 8 and 6 in reperfusion injury.

Authors:  T Kawamura; R Wakusawa; K Okada; S Inada
Journal:  Can J Anaesth       Date:  1993-11       Impact factor: 5.063

3.  Calculating correlation coefficients with repeated observations: Part 1--Correlation within subjects.

Authors:  J M Bland; D G Altman
Journal:  BMJ       Date:  1995-02-18

4.  Therapeutic Intervention Scoring System: update 1983.

Authors:  A R Keene; D J Cullen
Journal:  Crit Care Med       Date:  1983-01       Impact factor: 7.598

5.  Thyroid hormone treatment after coronary-artery bypass surgery.

Authors:  J D Klemperer; I Klein; M Gomez; R E Helm; K Ojamaa; S J Thomas; O W Isom; K Krieger
Journal:  N Engl J Med       Date:  1995-12-07       Impact factor: 91.245

6.  Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest.

Authors:  G Wernovsky; D Wypij; R A Jonas; J E Mayer; F L Hanley; P R Hickey; A Z Walsh; A C Chang; A R Castañeda; J W Newburger; D L Wessel
Journal:  Circulation       Date:  1995-10-15       Impact factor: 29.690

7.  Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure.

Authors:  L C Casey
Journal:  Ann Thorac Surg       Date:  1993-11       Impact factor: 4.330

8.  MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia.

Authors:  J Bernhagen; T Calandra; R A Mitchell; S B Martin; K J Tracey; W Voelter; K R Manogue; A Cerami; R Bucala
Journal:  Nature       Date:  1993-10-21       Impact factor: 49.962

9.  MIF as a glucocorticoid-induced modulator of cytokine production.

Authors:  T Calandra; J Bernhagen; C N Metz; L A Spiegel; M Bacher; T Donnelly; A Cerami; R Bucala
Journal:  Nature       Date:  1995-09-07       Impact factor: 49.962

10.  Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations.

Authors:  J D Klemperer; I L Klein; K Ojamaa; R E Helm; M Gomez; O W Isom; K H Krieger
Journal:  Ann Thorac Surg       Date:  1996-05       Impact factor: 4.330

View more
  6 in total

1.  High postoperative blood levels of macrophage migration inhibitory factor are associated with less organ dysfunction in patients after cardiac surgery.

Authors:  Christian Stoppe; Gerrit Grieb; Rolf Rossaint; David Simons; Mark Coburn; Andreas Götzenich; Tim Strüssmann; Norbert Pallua; Jürgen Bernhagen; Steffen Rex
Journal:  Mol Med       Date:  2012-07-18       Impact factor: 6.354

2.  Macrophage migration inhibitory factor induces cardiomyocyte apoptosis.

Authors:  Preeta Dhanantwari; Sumekala Nadaraj; Agnes Kenessey; Devyani Chowdhury; Yousef Al-Abed; Edmund J Miller; Kaie Ojamaa
Journal:  Biochem Biophys Res Commun       Date:  2008-04-24       Impact factor: 3.575

3.  Release of danger signals during ischemic storage of the liver: a potential marker of organ damage?

Authors:  Anding Liu; Hao Jin; Olaf Dirsch; Meihong Deng; Hai Huang; Martina Bröcker-Preuss; Uta Dahmen
Journal:  Mediators Inflamm       Date:  2010-12-21       Impact factor: 4.711

Review 4.  Hyperkalemic cardioplegia for adult and pediatric surgery: end of an era?

Authors:  Geoffrey P Dobson; Giuseppe Faggian; Francesco Onorati; Jakob Vinten-Johansen
Journal:  Front Physiol       Date:  2013-08-28       Impact factor: 4.566

5.  Brain injury with systemic inflammation in newborns with congenital heart disease undergoing heart surgery.

Authors:  Rossitza P Pironkova; Joseph Giamelli; Howard Seiden; Vincent A Parnell; Dorota Gruber; Cristina P Sison; Czeslawa Kowal; Kaie Ojamaa
Journal:  Exp Ther Med       Date:  2017-05-22       Impact factor: 2.447

Review 6.  Macrophage migration inhibitory factor (MIF) in the development and progression of pulmonary arterial hypertension.

Authors:  Mohamed Ahmed; Edmund Miller
Journal:  Glob Cardiol Sci Pract       Date:  2018-06-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.